Affy Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.02 K
- Company Age 34 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.93 Cr
- Satisfied Charges ₹ 26.01 Cr
About Affy Pharma
Affy Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 August 1990 and has a history of 34 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.02 K .
The company currently has active open charges totaling ₹4.93 Cr. The company has closed loans amounting to ₹26.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aditya Billa, Arvind Billa, and Sangeeta Billa serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232DL1990PTC425092
-
Company No.
005545
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Aug 1990
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Affy Pharma Private Limited offer?
Affy Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Contraceptives, Common Disease Medicines, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Affy Pharma?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aditya Billa | Director | 01-Jul-2018 | Current |
Arvind Billa | Director | 17-Aug-1990 | Current |
Sangeeta Billa | Director | 28-Oct-2001 | Current |
Financial Performance of Affy Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Affy Pharma?
Unlock access to Affy Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹49.29 M
₹260.11 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.00 Cr
- District Industries Centre S.W.C.A. Baddi (H.P.) : 1.90 Cr
- Citi Bank N.A. : 0.02 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Jul 2016 | Citi Bank N.A. | ₹0.24 M | Open |
28 Jan 2016 | Hdfc Bank Limited | ₹3.00 Cr | Open |
21 Dec 2010 | District Industries Centre S.W.C.A. Baddi (H.P.) | ₹1.90 Cr | Open |
24 May 2013 | Citibank N.A | ₹9.78 Cr | Satisfied |
20 Mar 2013 | Citibank N.A | ₹2.50 Cr | Satisfied |
How Many Employees Work at Affy Pharma?
Unlock and access historical data on people associated with Affy Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Affy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affy Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.